# US 2021/0275476 A1 · Bactericidal and virucidal pharmaceutical composition

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0275476 A1
- Document ID: US20210275476A1
- Status: Published application
- Kind: A1
- Application number: 17/199,822
- Filed: 2021-03-12
- Published: 2021-09-09
- Earliest claimed: 2015-10-05
- Assignees: Quimica Luar SRL
- Applicants: Quimica Luar SRL
- Inventors: Luis Alberto Argañarás; Adrian Javier Muñoz; Roxana Valeria Alasino; Ariel Gustavo Garro; Dante Miguel Beltramo
- Web page: https://patentgrep.com/patent/US20210275476A1

## CPC

- A61K 31/192: having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid {(cannabinoids A61K31/658)}
- A61K 9/08: Solutions {(composition of solutions A61K47/00)}
- A61K 9/19: lyophilised {, i.e. freeze-dried, solutions or dispersions (lyophilised products with subsequent particle size reduction A61K9/14; granules or pellets made by lyphilisation A61K9/1682; solid oral dosage forms made by lyophilisation A61K9/2095; lyophilisation additives A61K47/00)}
- A61K 33/14: Alkali metal chlorides; Alkaline earth metal chlorides
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61K 47/02: Inorganic compounds
- A61P 11/00: Drugs for disorders of the respiratory system
- A61P 31/04: Antibacterial agents
- A61P 31/12: Antivirals
- A61P 31/22: for herpes viruses
- A61K 47/26: Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A61K 47/36: Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A bactericidal and virucidal pharmaceutical composition for use on epithelial tissues such as pulmonary, nasal and oral tissues, which comprises a non-steroidal anti-inflammatory drug (NSAID) in a concentration between 5 and 500 mM and a salt, being the NSAID preferably solubilized in a hypertonic saline solution applicable in therapies for viral infections of the Herpes simplex type. The composition can be used in therapies for herpes simplex viral infections, be used as a bactericidal mouthwash, or be vehiculated to the lung by using a nebuliser, for cystic fibrosis.

## Claims

### Claim at position 1

1-33. (canceled)

### Claim 34

A pharmaceutical composition comprising ibuprofen or a pharmaceutically acceptable salt thereof in a concentration from 5 to 180 mM solubilized in a hypertonic saline solution comprising between 0.3 M and 2 M sodium chloride.

### Claim 35 (depends on 34)

The pharmaceutical composition of claim 34, wherein the concentration of ibuprofen or a pharmaceutically acceptable salt thereof in the hypertonic saline solution is from 5 to 80 mM.

### Claim 36 (depends on 34)

The pharmaceutical composition of claim 34, wherein the concentration of sodium chloride in the hypertonic saline solution is between 0.4 and 1.0 Molar.

### Claim 37 (depends on 36)

The pharmaceutical composition of claim 36, wherein the pH of the hypertonic saline solution is between 6.0 and 8.5.

### Claim 38 (depends on 34)

The pharmaceutical composition of claim 34, wherein the pharmaceutical composition is in a form suitable for administration by inhalation or is in a form suitable for nebulization or is a mouthwash or is in a form suitable for topical administration.

### Claim 39 (depends on 36)

The pharmaceutical composition of claim 36, wherein said pharmaceutical composition comprises a pharmaceutically acceptable salt of ibuprofen selected from the sodium salt of ibuprofen, the potassium salt of ibuprofen, the lithium salt of ibuprofen and a combination thereof.

### Claim 40 (depends on 34)

The pharmaceutical composition of claim 34, further comprising an anesthetic agent or an antibiotic agent.

### Claim 41 (depends on 40)

The pharmaceutical composition of claim 40, wherein said anesthetic agent is selected from the group consisting of xylocaine, lidocaine, mepivicaine and caricaine, and the antibiotic agent is selected from colistimethate sodium, tobramycin, ciprofloxacin, lysine, levofloxacin, ciprofloxacin aztreonam, fosfomycin, amphotericin B, vancomycin, gentamicin, ceftazidime, ampicillin and amikacin.

### Claim 42 (depends on 36)

The pharmaceutical composition of claim 36, wherein said pharmaceutical composition is in a form suitable for nebulization.

### Claim 43 (depends on 36)

The pharmaceutical composition of claim 36, wherein the pharmaceutical composition comprises the sodium salt of ibuprofen.

### Claim 44 (depends on 35)

The pharmaceutical composition of claim 35, wherein the hypertonic saline solution comprises between 0.4 M and 1 M sodium chloride.

### Claim 45 (depends on 44)

The pharmaceutical composition of claim 44, wherein the pH of the pharmaceutical composition is between 6.0 and 8.5.

### Claim 46 (depends on 44)

The pharmaceutical composition of claim 44, wherein the pharmaceutical composition is in a form suitable for nebulization.

### Claim 47 (depends on 44)

The pharmaceutical composition of claim 44, wherein said pharmaceutical composition comprises a pharmaceutically acceptable salt of ibuprofen selected from the sodium salt of ibuprofen, the potassium salt of ibuprofen, the lithium salt of ibuprofen and a combination thereof.

### Claim 48 (depends on 47)

The pharmaceutical composition of claim 47, wherein said pharmaceutical composition comprises the sodium salt of ibuprofen.

### Claim 49 (depends on 45)

The pharmaceutical composition of claim 45, wherein the pharmaceutical composition comprises the sodium salt of ibuprofen.

### Claim 50 (depends on 46)

The pharmaceutical composition of claim 46, wherein the pharmaceutical composition comprises the sodium salt of ibuprofen.

### Claim 51 (depends on 44)

The pharmaceutical composition of claim 44, wherein said anesthetic agent is selected from the group consisting of xylocaine, lidocaine, mepivicaine and caricaine, and the antibiotic agent is selected from colistimethate sodium, tobramycin, ciprofloxacin, lysine, levofloxacin, ciprofloxacin aztreonam, fosfomycin, amphotericin B, vancomycin, gentamicin, ceftazidime, ampicillin and amikacin.
